NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce the appointment of former U.S. Assistant Surgeon General, Rear Admiral Roscoe M. Moore, Jr. (USPHS, Ret) to the Company’s advisory board. Dr. Moore will add to the Company’s expertise with his 30 years of professional experience within the agencies of the US Public Health Service including, most recently, the US Food and Drug Administration and the Office of the US Secretary of Health and Human Services. Dr. Moore’s unique combination of experience in veterinary and human medical issues is particularly critical to Brainstorm as the company plans the transition from animal to human clinical trials.
